Blue Crest Capital Management LTD Amgen Inc Transaction History

Blue Crest Capital Management LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $430,998 - $520,269	-1,603 Reduced 54.54%	1,336 $379,000
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $306,328 - $345,575	1,198 Added 68.81%	2,939 $846,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $380,669 - $472,611	1,741 New	1,741 $467,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $298,691 - $396,146	-1,639 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $817,576 - $1.05 Million	-4,321 Reduced 72.5%	1,639 $395,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $1.04 Million - $1.24 Million	5,960 New	5,960 $1.15 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $2.88 Million - $3.38 Million	-17,305 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $254,845 - $287,266	1,409 Added 8.86%	17,305 $3.29 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $2.7 Million - $3.16 Million	-15,157 Reduced 48.81%	15,896 $3.09 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $4.76 Million - $5.36 Million	-25,668 Reduced 45.25%	31,053 $6.44 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $4.61 Million - $5.17 Million	27,744 Added 95.74%	56,721 $10.5 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $1 Million - $1.17 Million	5,906 Added 25.6%	28,977 $4.94 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $3.16 Million - $3.53 Million	-18,731 Reduced 44.81%	23,071 $4.01 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $6.99 Million - $7.98 Million	41,802	41,802 $7.79 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.